Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E H Flewellen

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Texas Medicine|October 1, 1980
Hazards of intravenous indigo carmine, fluorescein, and methylene blueE H Flewellen
Anesthesia and Analgesia|December 1, 1980
Burkitt's lymphoma and malignant hyperthermiaE H Flewellen
JAMA|May 3, 1976
Letter: Malignant hyperthermiaE H Flewellen
JAMA|June 27, 1986
Serum creatine kinase screening for susceptibility to malignant hyperthermiaE H Flewellen
Canadian Anaesthetists' Society Journal|November 1, 1979
Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?T E Nelson, E H Flewellen
JAMA|March 2, 1979
Ponderal index: quantifying obesityE H Flewellen, D E Bee
Canadian Anaesthetists' Society Journal|July 1, 1980
In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermiaE H Flewellen, T E Nelson
Anesthesia and Analgesia|July 1, 1984
Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?E H Flewellen, T E Nelson
Anesthesia and Analgesia|January 1, 1983
Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?E H Flewellen, T E Nelson
Anesthesiology|February 1, 1979
Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermiaT E Nelson, E H Flewellen
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Texas Medicine|October 1, 1980
Hazards of intravenous indigo carmine, fluorescein, and methylene blueE H Flewellen
Anesthesia and Analgesia|December 1, 1980
Burkitt's lymphoma and malignant hyperthermiaE H Flewellen
JAMA|May 3, 1976
Letter: Malignant hyperthermiaE H Flewellen
JAMA|June 27, 1986
Serum creatine kinase screening for susceptibility to malignant hyperthermiaE H Flewellen
Canadian Anaesthetists' Society Journal|November 1, 1979
Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?T E Nelson, E H Flewellen
JAMA|March 2, 1979
Ponderal index: quantifying obesityE H Flewellen, D E Bee
Canadian Anaesthetists' Society Journal|July 1, 1980
In vivo and in vitro responses to magnesium sulphate in porcine malignant hyperthermiaE H Flewellen, T E Nelson
Anesthesia and Analgesia|July 1, 1984
Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?E H Flewellen, T E Nelson
Anesthesia and Analgesia|January 1, 1983
Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?E H Flewellen, T E Nelson
Anesthesiology|February 1, 1979
Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermiaT E Nelson, E H Flewellen
Pageof 3